Biotechnologia Acta

...

  • Increase font size
  • Default font size
  • Decrease font size
Home Archive 2020 № 3 STUDIES OF EFFICIENCY OF THE COMPOSITE SYSTEM "LYMPHOSILICA" IN MODELING EXPERIMENTAL OBESITY IN RATS G. V. Ostrovska, T. V. Krupska, L. M. Pazyuk, M. E. Dzerzhynsky, V. V. Turov
Print PDF

ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)

Biotechnologia Acta V. 13, No 3, 2020
Р. 52-63, Bibliography 29, English
Universal Decimal Classification: 616-056.52+615.322
https://doi.org/10.15407/biotech13.03.052

STUDIES OF EFFICIENCY OF THE COMPOSITE SYSTEM "LYMPHOSILICA" IN MODELING EXPERIMENTAL OBESITY IN RATS

G. V. Ostrovska 1, T. V. Krupska 2, L. M. Pazyuk 1, M. E. Dzerzhynsky 1, V. V. Turov 2

1 ESC "Institute of Biology and Medicine" of Taras Shevchenko Kyiv National University
2 Chuiko Institute of Surface Chemistry of the National Academy of Sciences of Ukraine, Kyiv

The features of the influence of the nanocomposite system (Lymphosilica supplement), which was created on the basis of hydroconsolidated finely divided silica and plant materials with a high content of polyphenols, flavonoids, terpenes, polysaccharides on liver cytophysiological characteristics under the conditions of the development of metabolic syndrome and hepatotoxicity under simulated alimentary, were studied. Biochemical studies of blood serum and histological analysis of liver tissue were performed. It was shown that a high-calorie diet of rats over 100 days leads to the development of individual manifestations of obesity and metabolic syndrome, which are expressed in an increase in body weight and visceral fat, the development of the initial and middle stages of parenchymal fatty liver dystrophy with a decrease in morphological manifestations of the synthetic activity of the nucleus, with slight deviations at the biochemical level. The introduction of a phytocomposite does not lead to pathological changes in the organism of rats, but in some cases leads to manifestations of “adaptive stress” of liver hepatocytes, both with a standard diet and with a high-calorie diet. The positive effect of the composite system on reducing the proportion of visceral fat (by 38%) in rats with a standard diet was shown, and against the background of simulated alimentary obesity, normalization of the level of bilirubin (25 % decrease compared with alimentary obesity) and its fractions, lower levels cholesterol and alkaline phosphatase (in both cases by 19% compared with initial obesity), increased globulin fractions of blood serum, protective effect against dystrophic changes in liver tissue.

Key words: nanocomposite, Lymphosilica, nanosilica, rats, alimentary obesity, hepatocytes of theliver, visceralfat.

© Palladin Institute of Biochemistry of National Academy of Sciences of Ukraine, 2020

  • References
    • 1. Kukolevska O. S., Gerashchenko I. I., Pakhlov E. M. Nanocomposite materials with controlled release of bioactive substances. Proceedings NaUKMA. 2016, V. 183. Chemical sciences and technologies. P. 60–64. (InUkrainian).

      2. Karabanova L. V., Gomza Yu. P., Nesin S. D. O.M.Bondaruk. Nanocomposites based on multicomponent polymer matrice sandnano filler densil for biomedical application. Nanophysics, Nanophotonics, Surface Studies and Applications, Chapter 38, Springer. 2016, р. 451–475. https://doi.org/10.1007/978-3-319-30737-4_38

      3. Turov V. V., Gerashchenko I. I., Krupskaya T. V., Suvorova L. A. Nanochemistry in solving the problems of endo- and exoecology. Stavropol: Zebra. 2017, 315 p. (In Russian).

      4. Medical chemistry and clinical application of silica dioxide. Ed. Chuiko A. A. Kyiv: Nauk. dumka. 2003, 416 p. (In Russian).

      5. Viltsanyuk A. A., Gerashchenko I. I. Enterosorption in the complex treatment of acute surgical diseases of the abdominal organs. Kharkov. 2009, 128 p. (In Russian).

      6. Enterosorption. Ed. Belyakov N. A. Leningrad: Center for Sorption Technologies. 1991, 336 p. (In Russian).

      7. Anglin E. J., Cheng L., Freeman W. R., Sailov M. J. Sailor Porous silicon in drug delivery devices and materials. Adv. Drug Deliv. Rev. 2008, 60 (11), 1266–1277. https://doi.org/10.1016/j.addr.2008.03.017

      8. Coffer J. L., Whitehead M. A., Nagesha D. K. Porous siliconbased scaffolds for tissue engineering and other biomedical applications. Phys. Status Solidi Appl. Mat. 2005, 202 (8), 1451–1455. https://doi.org/10.1002/pssa.200461134

      9. Santos H. A., Mäkilä E., Airaksinen A. J., M , Hirvonen J.. Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications. Nanomedicine (Lond). 2014, 9 (4), 535–554. https://doi.org/10.2217/nnm.13.223

      10. Liu W., Chaix A., Gary-Bobo M. Stealth Biocompatible Si-Based Nanoparticles for Biomedical Applications. Nanomaterials (Basel). 2017, 7 (10), 288–302. https://doi.org/10.2217/nnm.13.223

      11. Rocha-García D., Guerra-Contreras A., Rosales-Mendoza S., Palestino G. Role of porous silicon/hydrogelcomposites on drug delivery. Mesoporous Biomater. 2016, V. 3, P. 93–101. https://doi.org/10.1515/mesbi-2016-0011

      12. Turov V. V., Krupska T. V., Golovan А. P., Аndriyko L. S., Кartel M. Т. Water binding in composite systems based on milled medicinal plants and nanosilica. Biotechnol. acta. 2017, 10 (2), 40–56. https://doi.org/10.15407/biotech10.02.040

      13. Wang S., Moustaid-Moussa N., Chen L. et al. Novel insights of dietary polyphenols and obesity. J. Nutr. Biochem. 2014, 25 (1), 1–18. https://doi.org/10.1016/j.jnutbio.2013.09.001

      14. Herranz-López M., Olivares-Vicente M., Encinar J. A,. Catalán E.,  Segura-Carretero A, Joven J.  Micol V.. Multi-Targeted Molecular Effects of Hibiscus sabdariffa Polyphenols: An Opportunity for a Global Approach to Obesity. Nutrients. 2017, 9 (8), 907. https://doi.org/10.3390/nu9080907

      15. Katsiki N., Mikhailidis D. P., Mantzoros C. S. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism. 2016, 65 (8), 1109–1123. https://doi.org/10.1016/j.metabol.2016.05.003

      16. Xiao J., Fai So K., Liong E. C., Tipoe G. L. Recent Advances in the Herbal Treatment of Non-Alcoholic Fatty Liver Disease. Journal of Traditional and Complementary Medicine. 2013, 3 (2), 88–94. https://doi.org/10.4103/2225-4110.110411

      17. Shen X. H., Tang Q., Huanet J. Cai W.. Vitamin E regulates adipocytokine expression in a ratmodel of dietary-induced obesity. Experimental biology and medicine. 2010, 235 (1), 47–51. 0.1258/ebm.2009.009122 · https://doi.org/10.1258/ebm.2009.009122

      18. Titov V. N., Tvorogova M. G. Methods for the study of bilirubin. Clinic. lab. diagnostics. 1994, N 5, P.36–38. (In Russian).

      19. Kotkina T. I., Volkova E. I., Titov V. N. The diagnostic value of a study of serum albumin. Labor. science. 1991, N 7, P.6–12. (In Russian).

      20. Titov V. N. Methods for the study of serum albumin. Clinic. lab. diagnostics. 1992, N 3‒4, P. 3–4. (In Russian).

      21. Titov V. N. Methodological aspects of the study of blood glucose. Clinic. lab. diagnostics. 1994, N 6, P. 4‒8. (In Russian).

      22. Clinical diagnosis ‒ laboratory fundamentals. Ed. of Menshikov V. V., with the participation of Dedova I. I., Makolkina V. I., Mukhina N. A. Moscow: Publishing house "Labinform". 1997, 320 p. (In Russian).

      23. Biochemical studies in the clinic. Elista: APP "Dzhangar". 1998, 250 p. (In Russian).

      24. Titov V. N., Bychkova N. A. Methodological and diagnostic aspects of the study of aminotransferase activity. Labor. science. 1990, N 8, P. 4‑12. (In Russian).

      25. Tvorogova M. G., Titov V. N. Alkaline phosphatase: research methods and diagnostic value. Labor. science. 1991, N 6, P. 10‑17. (In Russian).

      26. Chalasani N., Younossi Z.,  Lavine J.E.,  Diehl A.M.,  Brunt E.M., Cusi K., Charlton M.,  Sanyal A.J. . The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012, 55 (6), 2005–2023. doi: 10.1002/hep.25762. https://doi.org/10.1002/hep.25762

      27. Rosso N., Chavez-Tapia N.C., Tiribelli C., Bellentani S.. Translational approaches: from fatty liver to non-alcoholic steatohepatitis. World J. Gastroenterol. 2014, 20 (27), 9038–9049. doi: 10.3748/wjg.v20.i27.9038

      28. Strukov A. I., Surov V. V. Pathological anatomy. Moscow: GEOTAR-Media. 2015, 880 p. (In Ukrainian).

      29. Blagodarov V. Fundamentals of pathomorphology. Chastina 1 Zagalna pathomorphology. Kyiv: TOV Atlant YuEMSG. 2007, 198 p. (In Ukrainian).


 

Additional menu

Site search

Site navigation

Home Archive 2020 № 3 STUDIES OF EFFICIENCY OF THE COMPOSITE SYSTEM "LYMPHOSILICA" IN MODELING EXPERIMENTAL OBESITY IN RATS G. V. Ostrovska, T. V. Krupska, L. M. Pazyuk, M. E. Dzerzhynsky, V. V. Turov

Invitation to cooperation

Dear colleagues, we invite you to publish your articles in our journal.
© Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, 2008.
All rights are reserved. Complete or partial reprint of the journal is possible only with the written permission of the publisher.
E-mail
for information: biotech@biochem.kiev.ua.